X4 Pharmaceuticals (XFOR) Cash & Equivalents (2017 - 2026)
X4 Pharmaceuticals (XFOR) posted Cash & Equivalents of $195.1 million for Q2 2026, up 397.4% from $39.22 million a year earlier but down 10.1% from the prior quarter.
Powered by 
Analysis
X4 Pharmaceuticals (XFOR) Cash & Equivalents (2017 - 2026) Analysis & Trends
At the end of FY2025, X4 Pharmaceuticals' Cash & Equivalents came in at $217.05 million, up 289.7% from FY2024.
- Annual Cash & Equivalents shows a five-year compound annual growth rate of 22.5% (FY2020 to FY2025).
- In prior years, X4 Pharmaceuticals' Cash & Equivalents was $55.7 million in FY2024 (-43.9%), $99.22 million in FY2023 (-18.5%), $121.72 million in FY2022 (+48.8%) and $81.79 million in FY2021 (+3.9%).
- Quarterly Cash & Equivalents has run from a low of $39.22 million in Q2 2025 to a high of $217.05 million in Q4 2025 over five years.
- On a year-over-year basis, Cash & Equivalents has increased in each of the last three quarters, with growth averaging 115.1% over the last eight quarters.
- The strongest year-over-year quarter for Cash & Equivalents in the past five years was Q1 2026, with growth of 438.8%; the weakest was Q2 2025, with a decline of 73.4%.
- According to Business Quant data, Cash & Equivalents for the three prior quarters was $216.91 million (Q1 2026), $217.05 million (Q4 2025) and $69.63 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 8.95 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 20.42 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 6.57 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 6.85 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | 7.62 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | 4.89 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 13.99 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 3.18 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 976.00 Mn |
| 10 | X4 Pharmaceuticals | 357.55 Mn | -341.13 Mn | 7.19 Mn | 195.10 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 195.10 Mn |
| Mar 31, 2026 | 216.91 Mn |
| Dec 31, 2025 | 217.05 Mn |
| Sep 30, 2025 | 69.63 Mn |
| Jun 30, 2025 | 39.22 Mn |
| Mar 31, 2025 | 40.26 Mn |
| Dec 31, 2024 | 55.70 Mn |
| Sep 30, 2024 | 97.41 Mn |
| Jun 30, 2024 | 147.22 Mn |
| Mar 31, 2024 | 60.49 Mn |
| Dec 31, 2023 | 99.22 Mn |
| Sep 30, 2023 | 131.58 Mn |
| Jun 30, 2023 | 136.43 Mn |
| Mar 31, 2023 | 93.41 Mn |
| Dec 31, 2022 | 121.72 Mn |
| Sep 30, 2022 | 79.90 Mn |
| Jun 30, 2022 | 47.40 Mn |
| Mar 31, 2022 | 66.43 Mn |
| Dec 31, 2021 | 81.79 Mn |
| Sep 30, 2021 | 76.40 Mn |
API Access
X4 Pharmaceuticals Cash & Equivalents API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XFOR&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "cash-and-equivalents", "ticker": "XFOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=cash-and-equivalents&ticker=XFOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();